Press Releases

Company News
View Summary Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology
Feb 1, 2016
PDF 16.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology
Dec 17, 2015
PDF 17.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Receives 2015 Frost & Sullivan North American Opioid Oral Abuse Deterrence Technology Innovation Award
Nov 10, 2015
PDF 12.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Third Quarter 2015 Financial Results
Nov 4, 2015
PDF 24.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Third Quarter 2015 Financial Results Conference Call on November 5, 2015
Oct 28, 2015
PDF 11.7 KB Add to Briefcase
View Summary Acura Receives $2.5 Million Milestone Payment From Egalet Corporation
Oct 12, 2015
PDF 14.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Meets NASDAQ's Continuing Listing Requirement
Sep 16, 2015
PDF 15.1 KB Add to Briefcase
View Summary Egalet Corporation Launches Acura Pharmaceuticals' OXAYDO(TM)
Sep 9, 2015
PDF 16.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces 1-for-5 Reverse Stock Split
Aug 24, 2015
PDF 16.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Second Quarter 2015 Financial Results
Aug 3, 2015
PDF 27.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call on August 4, 2015
Jul 27, 2015
PDF 11.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Raise Approximately $7.6 Million From Institutional Healthcare Investors
Jul 1, 2015
PDF 13.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals USPTO Issues Notice of Allowance for Novel Limitx(TM) Abuse Deterrent Technology
Jun 29, 2015
PDF 14.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Partners Its Methamphetamine Resistant Impede(R) Technology
Jun 16, 2015
PDF 12.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces First Quarter 2015 Financial Results
May 4, 2015
PDF 22.4 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call on May 5, 2015
Apr 21, 2015
PDF 11.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Develop Abuse Deterrent Hydrocodone With Acetaminophen Tablets With Limitx(TM) Technology
Apr 9, 2015
PDF 14.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Reports Successful Topline Results From Nexafed(R) Extended-Release Clinical Study
Mar 23, 2015
PDF 13.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results
Mar 2, 2015
PDF 26.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host 2014 Financial Results Conference Call on March 3, 2015
Feb 23, 2015
PDF 11.2 KB Add to Briefcase
Showing 1-20 of 100 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase